Data / Form D filings / Porosome Therapeutics, Inc.
Porosome Therapeutics, Inc.: Form D filings
Porosome Therapeutics, Inc., a biotechnology company in Boston, MA, filed 5 Form D notices with the SEC between 2022 and 2026. The latest, on March 24, 2026, reports $3.6 million sold of an offering with no set size to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE BOSTON PLACE, STE 2631, Boston, MA, 02108
- Phone
- (781) 956-9799
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1934919
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | Amendment | Indefinite | $3,625,000 | 7 | Sep 8, 2023 | sec.gov | |
| Jun 3, 2025 | Amendment | Indefinite | $2,500,000 | 3 | Sep 8, 2023 | sec.gov | |
| Jul 25, 2024 | Amendment | Indefinite | $1,000,000 | 3 | Sep 8, 2023 | sec.gov | |
| Sep 14, 2023 | New notice | $5,000,000 | $1,500,024 | $3,499,976 | 3 | Sep 8, 2023 | sec.gov |
| Jun 24, 2022 | New notice | Indefinite | $305,000 | 3 | Jun 7, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Guillermo Marmol | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Mar 23, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Porosome Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.